Dr Chelsea B Pratt2024-12-05T10:04:01
Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and improve patient outcomes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-17T09:31:00Z
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, Drug Target Review
2025-03-19T15:00:00
Sponsored by Eurofins DiscoverX
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2026-10-30T07:00:00
Contributor Dr Shi-qi An, Drug Target Review
Site powered by Webvision Cloud